{
  "chunk_id": "V_iii_9_None_15",
  "content": "/>\nV.iii.9.2.a\n.\nAssigning a  P&T Evaluation for AL Amyloidosis\nAssign a permanent and total (P&T) evaluation for amyloid light chains (AL) amyloidosis (primary amyloidosis).  AL amyloidosis is considered incurable and progressive.\nNotes\n:\nEvaluate AL amyloidosis under\n38 CFR 4.117, DC 7717\n.\nConsider ancillary benefits associated with the award of P&T disability evaluations.\nAL amyloidosis is a disability that is presumptively associated with herbicide exposure.\nReferences\n:  For more information on\nrating disabilities associated with herbicide exposure, see\nM21-1, Part VIII, Subpart i, 1.B\n, and\naddressing claims for P&T evaluation based on malignancy prognosis, see\nM21-1, Part V, Subpart ii, 3.D.4.f\n.",
  "title": "M21-1, Part V, Subpart iii, Chapter 9 - Hematologic and Lymphatic Systems",
  "citation": "Part V, Subpart iii, Chapter 9, Section None",
  "source_url": "https://www.knowva.ebenefits.va.gov/system/templates/selfservice/va_ssnew/help/customer/locale/en-US/portal/554400000001018/content/554400000180513/M21-1-Part-V-Subpart-iii-Chapter-9-Hematologic-and-Lymphatic-Systems",
  "updated": "",
  "scraped_at": "2025-06-16T22:45:35.239285",
  "tags": [
    "m21-1"
  ]
}